Navigation Links
Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook
Date:4/24/2009

ABBOTT PARK, Ill., April 24 /PRNewswire-FirstCall/ -- Abbott's diversified portfolio of businesses generated industry-leading results across the company in 2008 and remain strong and focused for the future, Chairman and Chief Executive Officer Miles D. White told shareholders today at the company's annual meeting.

"Abbott had a truly outstanding year in 2008 across all of our major businesses - medical devices, nutritional products, diagnostics and pharmaceuticals," said Mr. White. "We delivered on our strategic, operational and financial goals, strengthened our leadership positions across our range of global businesses, and we executed a record nine major new product launches."

Value of Diversity

Balanced growth across the company's major businesses drove another year of double-digit ongoing earnings growth in 2008. Abbott's business portfolio, enhanced by the February 2009 acquisition of Advanced Medical Optics, a global leader in vision care and surgery, generates sustainable growth, particularly in the current economic environment.

Over the last one, three and five years, Abbott's total return, which includes stock price performance and dividends, has significantly outperformed the S&P 500 Index and the majority of its health care peers. Abbott's top-tier total return is due, in part, to the company's 36th consecutive annual increase in its cash dividend, amid widespread dividend reductions across industries. This year, Abbott increased its dividend by 11 percent.

"Our company remains strong, focused, and ready for the future," said Mr. White. "The steps we've taken in recent years to strengthen our company with a diverse mix of businesses stand us in very good stead for these times.
'/>"/>

SOURCE Abbott Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
2. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
3. Abbott Hosts Conference Call for First-Quarter Earnings
4. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
5. Abbott to Present at Cowen Annual Health Care Conference
6. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
7. Abbott Completes Acquisition of Advanced Medical Optics
8. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
9. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
10. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
11. Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Ca (PRWEB) , ... September 03, 2015 , ... According ... a promising and convenient test that may help patients with oropharyngeal cancer (oral cancer) ... in the United States are often caused by HPV infections, which have a high ...
(Date:9/3/2015)... Washington, DC (PRWEB) , ... September 03, 2015 ... ... announce the speakers for its upcoming virtual conference, “Proven Pharmacy Benefit Strategies for ... companies such as CVS Health, Express Scripts and Milliman, will discuss how plan ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions ... eCOA Congress in Lisbon, Portugal, September 22-24, 2015. The esteemed faculty of ...
(Date:9/3/2015)... ... , ... A scar is an unavoidable result of incision or injury to the skin. Unsightly ... heal itself. The appearance of a scar is dependent on many factors – the size ... ”Many scars fade to near invisibility on their own over a period of months,” says ...
(Date:9/3/2015)... ... ... n Me is pleased to announce the launch of its Baby Car Seat ... sun exposure, wind, bugs, and germs. The Mum n Me Baby Car Seat Cover ... securely in place. The new car seat cover is made with breathable cotton muslin ...
Breaking Medicine News(10 mins):Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:Mum n Me Announces New Baby Car Seat Cover 2
... Lay, the founder of Enron, who was admitted at the ... the early morning due to a heart attack//. ... had succumbed to his illness just months before his impending ... founder of the Enron Corp. was convicted on 10 counts ...
... in New Brunswick, New Jersey have reported that breast ... wetting //as children since they seem to have a ... inferring that breast-feeding protects against bed-wetting and our results ... added that there was sufficient evidence that bed-wetting can ...
... an important move that will benefit poor patients, the Centre ... prestigious All India Institute// of Medical Sciences (AIIMS). ,The ... was taken at a meeting of the AIIMS Institute Body ... to be rolled back., ,"The Union Health Ministry has ...
... attractive sachets is fast replacing the traditional paan in Pakistan, ... that both are banned, says a media report. ,In ... gutka, is being marketed daily. ,The government ... "too great". "In fact it is registered as an important ...
... of relieving pain, say researchers from the University College London. ... understand the behavior of pain receptors within cells. ... effect. Scientists rated the benefits of heat for pain relief ... turned off at the molecular level, when exposed to heat. ...
... (MIMR) have developed a new machine, named near-infrared spectroscopy, ... ,Although it was the first of its ... fluctuating BP and brain oxygen levels of a preterm ... of Medical Research (MIMR) are carrying out studies to ...
Cached Medicine News:Health News:Preterm Babies Benefited from a New NI Spectroscopy 2
(Date:9/2/2015)... , Sept. 2, 2015 Amgen ... of a Marketing Authorization Application (MAA) to the ... for etelcalcetide (formerly AMG 416) for the treatment ... chronic kidney disease (CKD) on hemodialysis therapy. If ... that can be administered intravenously. Etelcalcetide ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP ... bellwether trial will commence October 13, 2015. ... the 510K fast-track approval program, Zimmer NexGen knee implant ... only requires that companies provide evidence that the product ... in order to gain permissions. In ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015  Research ... addition of the "An Introduction to the ... 2015)" conference to their offering. ... the European medical device legislation. It will explain ... involvement of Notified Bodies, how to choose one ...
Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... is a CO2 laser system with ... Its functions in continuous and super-pulsed ... extreme laser intervention delicacy. Excellent as ... it comes with a large LCD ...
Auto Refkeratomoeter...
Developed to meet the infusion needs in NICU, Anesthesia and Critical Care, the AUTO SYRINGE AS50 Infusion Pump delivers precise, controlled infusions....
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: